Filter Search


Europe


Location Summary Deadline
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Botulinum Toxin Type A (obo), Atc M03ax21 For The Period 01.12.2024 - 30.11.2026 2026-10-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Botulinum Toxin Type A (obo), Atc M03ax21 For The Period 01.12.2024 30.11.2026 2026-10-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Glatiramer Acetate (only Prefilled Syringes), (obo), Atc L03ax13 For The Period 01.12.2024 - 30.11.2026 2026-10-05
Germany Open House Drug Discount Agreements Bosutinib, Atc L01ea04 2026-10-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Cladribine (obo), Atc L04aa40 For The Period 01.12.2024 30.11.2026 2026-10-05
Germany Open House Drug Discount Agreements Trastuzumab, Atc L01fd01 2026-10-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a, Paragraph 8 Of The Social Code Book V For The Active Ingredient Erythropoietin (exclusively Epoetin Zeta), (obo), Atc B03xa01 For The Period 01.12.2024 30.11.2026 2026-10-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Clomipramine (obg), Atc N06aa04 For The Period 01.12.2024 30.11.2026 2026-10-05
Germany Open House Drug Discount Agreements Chlorthalidone, Atc C03ba04 2026-10-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Clomipramine (obg), Atc N06aa04 For The Period 01.12.2024 - 30.11.2026 2026-10-05
Whats app